Pharmacokinetic-Pharmacodynamic Comparison of Recombinant and Plasma-Derived von Willebrand Factor in Patients with von Willebrand Disease Type 3.

Alexander BauerSofia Friberg-HietalaGiovanni SmaniaMartin J Wolfsegger

Published in: Journal of blood medicine (2023)

The slower elimination of VWF:RCo following rVWF administration results in a prolonged effect on FVIII turnover compared with pdVWF/FVIII administration.

Keyphrases

bone mineral density
cell free
body composition
postmenopausal women